Effect of adjuvant trastuzumab among patients treated with anti-HER2-based neoadjuvant therapy. [electronic resource]
Producer: 20150501Description: 630-5 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Carcinoma, Ductal, Breast -- drug therapy
- Chemotherapy, Adjuvant
- Cyclophosphamide -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Middle Aged
- Neoadjuvant Therapy
- Paclitaxel -- administration & dosage
- Protein Kinase Inhibitors -- administration & dosage
- Receptor, ErbB-2 -- antagonists & inhibitors
- Retrospective Studies
- Trastuzumab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.